A investigation squad astatine CiQUS (University of Santiago de Compostela, Spain) has unveiled an innovative molecular attack that enables anticancer narcotics to scope nan nucleus of tumor cells, wherever they tin exert their therapeutic effect. The study focused connected doxorubicin, a wide utilized chemotherapy agent. Prolonged vulnerability to this supplier often leads to nan emergence of resistant cells, a awesome objective situation that this strategy successfully overcomes while preserving nan drug's antitumor activity.
The attack builds connected a elemental but powerful concept: nan expertise of cyclic peptides -small amino acerb rings- to stack and self-assemble into hollow cylindrical structures (nanotubes) connected nan aboveground of crab compartment membranes. The system, developed by nan squad led by Juan R. Granja, couples doxorubicin to these peptides and directs it to nan compartment nucleus done a transportation pathway that differs from nan drug's accustomed mechanism. This allows nan supplier to bypass nan cellular guidance mechanisms that would usually deactivate it.
Compared pinch patient cells, crab compartment membranes incorporate higher levels of negatively charged lipids. The cyclic peptides utilized successful this study show a beardown affinity for these anionic surfaces, facilitating their relationship pinch tumor cells. As a result, nan peptide–drug conjugates participate resistant cells and recreation towards nan nucleus, wherever doxorubicin intercalates pinch DNA to trigger its cytotoxic effect.
Experimental studies confirmed that nan chemic building of nan cyclic peptide is cardinal to nan statement of unchangeable nanotubes, which successful move enhances their expertise to penetrate malignant cells. The work, published successful ACS Applied Materials & Interfaces, was carried retired astatine CiQUS, a investigation centre recognised arsenic a CIGUS by nan Xunta de Galicia and supported by nan European Union done nan Galicia FEDER Programme 2021–2027.
Drug guidance remains 1 of nan main obstacles successful crab therapy. Many tumors create mechanisms to actively expel drugs, greatly limiting the efficacy of disposable treatments. In this context, cyclic peptides enactment arsenic highly businesslike transportation vehicles, tin of introducing doxorubicin into cells that would usually cull it.
By combining selectivity, businesslike transport, and controlled supplier release, this strategy paves nan measurement for caller operation chemotherapies successful which peptide-based nanotechnology could go a powerful state against cancer. The authors dream this attack will animate nan improvement of caller therapeutic strategies targeting hard-to-treat tumors.
Source:
Journal reference:
Vilela-Picos, M., et al. (2025). Self-Assembling Cyclic Peptide Nanotubes for nan Delivery of Doxorubicin into Drug-Resistant Cancer Cells. ACS Applied Materials & Interfaces. doi.org/10.1021/acsami.5c05264
English (US) ·
Indonesian (ID) ·